510(k) · Cleared
ClearedTerumo 31G Thinpro Insulin Syringe
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Terumo Medical Corp. · FMF Syringe, Piston
Cleared on Jul 11, 2007 as substantially equivalent to K822083 (Terumo Medical Corp., 1982) and 3 other predicates after a 27-day review. Its family tree reaches back 2 generations to 1982. 82 later devices descend from it.
- Decided
- Jul 11, 2007
- Review
- 27 days
- Class
- Class II
- Product code
- FMF
- Recalls
- None
- Predicates
- 4
Its longest line of descent runs back 2 generations to K822083 (1982). 4 ancestors in all. 82 later devices descend from it, 3 citing it directly.
- Root · 2 generations backK822083 U-100 Insulin SyringeTerumo Medical Corp. · 1982
- 1 generation backK992802 Terumo U-100 Insulin SyringeTerumo Medical Corp. · 1999
- This deviceK071630 Terumo 31G Thinpro Insulin SyringeTerumo Medical Corp. · 2007
- Descendant · cites it directly · 78 of its ownK072739 Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd. · 2008
- Descendant · 2 generations on · 36 of its ownK110421 Disposable Insulin SyringeWenzhou Wuzhou Import & Export Co., Ltd. · 2011
- Descendant · 2 generations on · 31 of its ownK112057 KDL Syringes and NeedleShanghai Kindly Enterprise Dev. Group Co., · 2011
- Descendant · 3 generations on · 13 of its ownK190002 Sterile Hypodermic Syringe for Single use, with/without needle…Shanghai Kohope Medical Devices Co., Ltd. · 2019
- Descendant · 2 generations on · 12 of its ownK180417 Self-destruction Safety Syringes for Single Use; Sterile Hypodermic…Berpu Medical Technology Co., Ltd. · 2018
Showing 5 of 82 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 82 · See all- K072739Jierui Syringes and NeedlesShandong Weigao Group Medical Polymer Co., Ltd. · 2008 · cites it directly78descendants
- K110421Disposable Insulin SyringeWenzhou Wuzhou Import & Export Co., Ltd. · 2011 · 2 generations on36descendants
- K112057KDL Syringes and NeedleShanghai Kindly Enterprise Dev. Group Co., · 2011 · 2 generations on31descendants
- K190002Sterile Hypodermic Syringe for Single use, with/without needle, Sterile Insulin Syringe…Shanghai Kohope Medical Devices Co., Ltd. · 2019 · 3 generations on13descendants
- K180417Self-destruction Safety Syringes for Single Use; Sterile Hypodermic Syringes for Single…Berpu Medical Technology Co., Ltd. · 2018 · 2 generations on12descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K822083 | U-100 Insulin Syringe | Terumo Medical Corp. | 1982 | — |
| −1 | K992802 | Terumo U-100 Insulin Syringe | Terumo Medical Corp. | 1999 | — |
| 0 (this device) | K071630 | Terumo 31G Thinpro Insulin Syringe | Terumo Medical Corp. | 2007 | — |
| +1 | K072739 | Jierui Syringes and Needles | Shandong Weigao Group Medical Polymer Co., Ltd. | 2008 | — |
| +2 | K110421 | Disposable Insulin Syringe | Wenzhou Wuzhou Import & Export Co., Ltd. | 2011 | — |
| +2 | K112057 | KDL Syringes and Needle | Shanghai Kindly Enterprise Dev. Group Co., | 2011 | — |
| +3 | K190002 | Sterile Hypodermic Syringe for Single use, with/without needle, Sterile… | Shanghai Kohope Medical Devices Co., Ltd. | 2019 | — |
| +2 | K180417 | Self-destruction Safety Syringes for Single Use; Sterile Hypodermic Syringes… | Berpu Medical Technology Co., Ltd. | 2018 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 1 | 0 |
| 2000 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
| 2011 | 4 | 0 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2015 | 1 | 0 |
| 2016 | 3 | 0 |
| 2017 | 5 | 0 |
| 2018 | 3 | 0 |
| 2019 | 2 | 0 |
| 2020 | 4 | 0 |
| 2021 | 13 | 0 |
| 2022 | 13 | 0 |
| 2023 | 15 | 0 |
| 2024 | 6 | 0 |
| 2025 | 6 | 0 |
| 2026 | 3 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in FMF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new FMF device
- #1 K241821 Luer Lock Syringe with Safety Needle; Luer…score 16.2 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (4)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K822083 | U-100 Insulin SyringeSummary page 1…ubstantially equivalent in intended use, design, technology/principles of operation, materials and performance to the cleared TERUMO®k Insulin Syringe (K822083, K992802, & KOO 1474 -Pediatric Indication) and the Becton Dickinson® Ultra-Fine TM II Insulin Syringe (K955235). PRIN… | 1982 |
| * | K992802 | Terumo U-100 Insulin SyringeSummary page 1…lly equivalent in intended use, design, technology/principles of operation, materials and performance to the cleared TERUMO®k Insulin Syringe (K822083, K992802, & KOO 1474 -Pediatric Indication) and the Becton Dickinson® Ultra-Fine TM II Insulin Syringe (K955235). PRINCIPLE OF… | 1999 |
| * | K001474 | Terumo U-100 Insulin SyringSummary page 1…device is operated manually. MATERIALS The materials used in this device are the same as used in the TERIJMO® Insulin Syringe (K822083 , K992802, & K00 1474 - Pediatric Indication>- 09 C~… | 2000 |
| * | K955235 | B-D Ultra Fine II, Micro Fine + Short Needle Insulin SyringeSummary page 1…o the cleared TERUMO®k Insulin Syringe (K822083, K992802, & KOO 1474 -Pediatric Indication) and the Becton Dickinson® Ultra-Fine TM II Insulin Syringe (K955235). PRINCIPLE OF OPERATION/TECHNOLOGY This device is operated manually. MATERIALS The materials used in thi… | 1996 |
What descends from it? (82)
See all 823 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 25 years and passes through 1 company; a new generation was cleared every 17.1 years on median.
- 1 of the 4 ancestors has a recall of any class.
- Of its descendants, K072739 (Shandong Weigao Group Medical Polymer Co., Ltd., 2008) has gone furthest, with 78 descendants of its own.
- 3 other devices also cite its predicate K822083.
How does its category compare?
All FMF devicesFMF Syringe, Piston: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · FMF
13in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · FMF
114in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · FMF
19in 2023
Class I (19 since 2007) Class II/III not classified
Adverse event reports per year · FMF
4,181in 2025
MAUDE reports naming product code FMF, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 23 | 90 | 6 | 674 |
| 2008 | 9 | 74 | 11 | 691 |
| 2009 | 14 | 94 | 15 | 913 |
| 2010 | 11 | 130 | 12 | 679 |
| 2011 | 16 | 109 | 3 | 186 |
| 2012 | 9 | 86 | 6 | 307 |
| 2013 | 12 | 154 | 1 | 326 |
| 2014 | 13 | 84 | 1 | 244 |
| 2015 | 11 | 87 | 2 | 273 |
| 2016 | 12 | 146 | 0 | 684 |
| 2017 | 13 | 135 | 3 | 1,858 |
| 2018 | 8 | 87 | 2 | 3,952 |
| 2019 | 11 | 146 | 1 | 5,863 |
| 2020 | 15 | 107 | 2 | 5,334 |
| 2021 | 20 | 175 | 1 | 5,874 |
| 2022 | 24 | 211 | 2 | 5,233 |
| 2023 | 22 | 173 | 19 (18) | 5,214 |
| 2024 | 14 | 130 | 0 | 5,122 |
| 2025 | 13 | 114 | 0 | 4,181 |
| 2026 | 9 | 239 | 2 (1) | — |
What is it indicated for?
The TERUMO® 31G ThinPro Insulin Syringe, with fixed hypodermic single lumen needle, is a device intended for medical purposes for the manual aspiration of fluids, and for the injection of fluids into parts of the body below the surface of the skin. This device is intended particularly for the aspiration and injection of insulin. This syringe with 31G needle is indicated for general use and for pediatric patients.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K071630 · printed Nov 4, 2026
Cite this page
510(k) Report. “K071630: Terumo 31G Thinpro Insulin Syringe.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071630
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026